Aaron Kantoff Centessa Pharmaceuticals PLC (CNTA) insider trading activity

CNTA Quotes by TradingView

Aaron Kantoff is Director of Centessa Pharmaceuticals plc. Currently has a direct ownership of 60,000 shares of CNTA, which is worth approximately $940,200. The most recent transaction as insider was on Nov 18, 2021, when has been sold 10,000 shares (Ordinary Shares) at a price of $11.98 per share, resulting in proceeds of $119,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 60K
0% 3M change
0% 12M change
Total Value Held $940,200

AARON KANTOFF Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 18 2021
BUY
Open market or private purchase
$119,800 $11.98 p/Share
10,000 Added 14.29%
60,000 Ordinary Shares

Also insider at

TALS
Talaris Therapeutics, Inc. Healthcare
Director
AVTX
Avalo Therapeutics, Inc. Healthcare
Director
AK

Aaron Kantoff

Director
Cheshire, X0

Track Institutional and Insider Activities on CNTA

Follow Centessa Pharmaceuticals plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CNTA shares.

Notify only if

Insider Trading

Get notified when an Centessa Pharmaceuticals PLC insider buys or sells CNTA shares.

Notify only if

News

Receive news related to Centessa Pharmaceuticals plc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CNTA